BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen JW, Bhandari M, Astill DS, Wilson TG, Kow L, Brooke-Smith M, Toouli J, Padbury RT. Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion. HPB (Oxford). 2010;12:101-108. [PMID: 20495653 DOI: 10.1111/j.1477-2574.2009.00140.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Demirci NS, Erdem GU. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in patients with operable ampullary carcinoma. Bosn J Basic Med Sci 2018;18:268-74. [PMID: 29131967 DOI: 10.17305/bjbms.2017.2530] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Fouquet T, Germain A, Brunaud L, Bresler L, Ayav A. Is perineural invasion more accurate than other factors to predict early recurrence after pancreatoduodenectomy for pancreatic head adenocarcinoma? World J Surg. 2014;38:2132-2137. [PMID: 24715041 DOI: 10.1007/s00268-014-2465-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
3 Liang D, Shi S, Xu J, Zhang B, Qin Y, Ji S, Xu W, Liu J, Liu L, Liu C. New insights into perineural invasion of pancreatic cancer: More than pain. Biochim Biophys Acta. 2016;1865:111-122. [PMID: 26794395 DOI: 10.1016/j.bbcan.2016.01.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
4 Cherenfant J, Stocker SJ, Gage MK, Du H, Thurow TA, Odeleye M, Schimpke SW, Kaul KL, Hall CR, Lamzabi I, Gattuso P, Winchester DJ, Marsh RW, Roggin KK, Bentrem DJ, Baker MS, Prinz RA, Talamonti MS. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery 2013;154:785-93. [DOI: 10.1016/j.surg.2013.07.004] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 9.0] [Reference Citation Analysis]
5 Bapat AA, Hostetter G, Von Hoff DD, Han H. Perineural invasion and associated pain in pancreatic cancer. Nat Rev Cancer 2011;11:695-707. [DOI: 10.1038/nrc3131] [Cited by in Crossref: 207] [Cited by in F6Publishing: 202] [Article Influence: 18.8] [Reference Citation Analysis]
6 Almeida RVS, Pacheco AM Jr, Silva RA, Moricz A, Campos T. Angiolymphatic invasion as a prognostic fator in resected N0 pancreatic adenocarcinoma. Arq Bras Cir Dig 2017;30:42-6. [PMID: 28489168 DOI: 10.1590/0102-6720201700010012] [Reference Citation Analysis]
7 Shao Z, Chaudhri S, Guo M, Zhang L, Rea D. Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study. Oncol Res 2016;23:291-302. [PMID: 27131315 DOI: 10.3727/096504016X14562725373879] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
8 Chaux A, Cubilla AL. Stratification systems as prognostic tools for defining risk of lymph node metastasis in penile squamous cell carcinomas. Seminars in Diagnostic Pathology 2012;29:83-9. [DOI: 10.1053/j.semdp.2011.08.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
9 Dasari BV, Roberts KJ, Hodson J, Stevens L, Smith AM, Hubscher SG, Isaac J, Muiesan P, Sutcliffe RP, Marudanayagam R, Mirza DF. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio. HPB (Oxford) 2016;18:332-8. [PMID: 27037202 DOI: 10.1016/j.hpb.2015.11.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
10 DeCoste R, McDonell LM, Uzans D, Molinari M, Huang WY. Comparing Pathology Report Quality Indicators in 2 Distinct Whipple Resection Specimen Protocols. Pancreas 2020;49:788-92. [PMID: 32541634 DOI: 10.1097/MPA.0000000000001574] [Reference Citation Analysis]
11 Elberm H, Ravikumar R, Sabin C, Abu Hilal M, Al-Hilli A, Aroori S, Bond-Smith G, Bramhall S, Coldham C, Hammond J. Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection for Pancreatic Cancer Study Group. Eur J Surg Oncol. 2015;41:1500-1507. [PMID: 26346183 DOI: 10.1016/j.ejso.2015.08.158] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
12 Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, Kim HJ, Cho CK. Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion. Surg Today. 2014;44:1879-1886. [PMID: 24535697 DOI: 10.1007/s00595-014-0846-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
13 Kurlinkus B, Ahola R, Zwart E, Halimi A, Yilmaz BS, Ceyhan GO, Laukkarinen J. In the Era of the Leeds Protocol: A Systematic Review and A Meta-Analysis on the Effect of Resection Margins on Survival Among Pancreatic Ductal Adenocarcinoma Patients. Scand J Surg 2020;109:11-7. [PMID: 32192417 DOI: 10.1177/1457496920911807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Fink DM, Steele MM, Hollingsworth MA. The lymphatic system and pancreatic cancer. Cancer Lett 2016;381:217-36. [PMID: 26742462 DOI: 10.1016/j.canlet.2015.11.048] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
15 Sukharamwala P, Thoens J, Szuchmacher M, Smith J, DeVito P. Advanced age is a risk factor for post-operative complications and mortality after a pancreaticoduodenectomy: a meta-analysis and systematic review. HPB (Oxford) 2012;14:649-57. [PMID: 22954000 DOI: 10.1111/j.1477-2574.2012.00506.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 73] [Article Influence: 8.8] [Reference Citation Analysis]
16 Metildi CA, Kaushal S, Hardamon CR, Snyder CS, Pu M, Messer KS, Talamini MA, Hoffman RM, Bouvet M. Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models. J Am Coll Surg. 2012;215:126-135; discussion 135-136. [PMID: 22632917 DOI: 10.1016/j.jamcollsurg.2012.02.021] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
17 Nagakawa Y, Yi SQ, Takishita C, Sahara Y, Osakabe H, Kiya Y, Yamaguchi H, Miwa Y, Sato I, Tsuchida A. Precise anatomical resection based on structures of nerve and fibrous tissue around the superior mesenteric artery for mesopancreas dissection in pancreaticoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci 2020;27:342-51. [PMID: 32048456 DOI: 10.1002/jhbp.725] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
18 Gasparini G, Pellegatta M, Crippa S, Lena MS, Belfiori G, Doglioni C, Taveggia C, Falconi M. Nerves and Pancreatic Cancer: New Insights into a Dangerous Relationship. Cancers (Basel) 2019;11:E893. [PMID: 31248001 DOI: 10.3390/cancers11070893] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
19 Robinson SM, Rahman A, Haugk B, French JJ, Manas DM, Jaques BC, Charnley RM, White SA. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2012;38:333-339. [PMID: 22317758 DOI: 10.1016/j.ejso.2011.12.020] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
20 Colussi O, Voron T, Pozet A, Hammel P, Sauvanet A, Bachet J, Vaillant J, Rougier P, Nordlinger B, Berger A, Coriat R, Dousset B, Malka D, André T, Paye F, Aparicio T, Locher C, Cojean Zeleck D, Tchinou L, Bonnetain F, Taieb J. Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort. European Journal of Surgical Oncology (EJSO) 2015;41:520-6. [DOI: 10.1016/j.ejso.2015.01.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
21 Sahakyan MA, Kim SC, Kleive D, Kazaryan AM, Song KB, Ignjatovic D, Buanes T, Røsok BI, Labori KJ, Edwin B. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: Long-term oncologic outcomes after standard resection. Surgery 2017;162:802-11. [PMID: 28756944 DOI: 10.1016/j.surg.2017.06.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
22 Kakar S, Pawlik TM, Allen PJ, Vauthey J. Exocrine Pancreas. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, editors. AJCC Cancer Staging Manual. Cham: Springer International Publishing; 2017. pp. 337-47. [DOI: 10.1007/978-3-319-40618-3_28] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
23 Lee CHA, Shingler G, Mowbray NG, Al-Sarireh B, Evans P, Smith M, Usatoff V, Pilgrim C. Surgical outcomes for duodenal adenoma and adenocarcinoma: a multicentre study in Australia and the United Kingdom. ANZ J Surg. 2018;88:E157-E161. [PMID: 28122405 DOI: 10.1111/ans.13873] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
24 Kleine M, Schrem H, Vondran FW, Krech T, Klempnauer J, Bektas H. Extended surgery for advanced pancreatic endocrine tumours. Br J Surg 2012;99:88-94. [PMID: 22135173 DOI: 10.1002/bjs.7681] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
25 Fathi AH, Romanyshyn J, Barati M, Choudhury U, Chen A, Sosa JA. Predicting Aggressive Behavior in Nonfunctional Pancreatic Neuroendocrine Tumors With Emphasis on Tumor Size Significance and Survival Trends: A Population-Based Analysis of 1787 Patients. Am Surg 2020;86:458-66. [PMID: 32684030 DOI: 10.1177/0003134820919730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Chatterjee D, Katz MH, Rashid A, Wang H, Iuga AC, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Crane CH, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol. 2012;36:409-417. [PMID: 22301497 DOI: 10.1097/pas.0b013e31824104c5] [Cited by in Crossref: 94] [Cited by in F6Publishing: 53] [Article Influence: 9.4] [Reference Citation Analysis]
27 Kanhere HA, Trochsler MI, Kanhere MH, Lord AN, Maddern GJ. Pancreaticoduodenectomy: Outcomes in a Low-Volume, Specialised Hepato Pancreato Biliary Unit. World J Surg 2014;38:1484-90. [DOI: 10.1007/s00268-013-2431-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
28 Plichta JK, Godambe AS, Fridirici Z, Yong S, Sinacore JM, Abood GJ, Aranha GV. The Association between Survival and the Pathologic Features of Periampullary Tumors Varies over Time. HPB Surg 2014;2014:890530. [PMID: 25104878 DOI: 10.1155/2014/890530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
29 Wylie N, Adib R, Barbour AP, Fawcett J, Hill A, Lynch S, Martin I, O'Rourke TR, Puhalla H, Rutherford L, Slater K, Whiteman DC, Neale RE; Queensland Pancreatic Cancer Study Group. Surgical management in patients with pancreatic cancer: a Queensland perspective. ANZ J Surg 2013;83:859-64. [PMID: 23095039 DOI: 10.1111/j.1445-2197.2012.06312.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
30 Mohindroo C, Hasanov M, Rogers JE, Dong W, Prakash LR, Baydogan S, Mizrahi JD, Overman MJ, Varadhachary GR, Wolff RA, Javle MM, Fogelman DR, Lotze MT, Kim MP, Katz MHG, Pant S, Tzeng CD, McAllister F. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients. Cancer Med 2021;10:5041-50. [PMID: 34250759 DOI: 10.1002/cam4.3870] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Herlea V, Mustafa ES, Iorgescu AC, Pechianu NC, Cretoiu D, Sajin M, Dima SO, Vasilescu C, Stroescu C, Ungureanu C, Dumitrascu T, Brasoveanu V, Ghinescu M, Popescu I. A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma. J Immunol Res 2020;2020:6148286. [PMID: 33062723 DOI: 10.1155/2020/6148286] [Reference Citation Analysis]
32 Chatterjee D, Rashid A, Wang H, Katz MH, Wolff RA, Varadhachary GR, Lee JE, Pisters PW, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy. Am J Surg Pathol 2012;36:552-9. [PMID: 22301496 DOI: 10.1097/PAS.0b013e318240c1c0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
33 Wrona E, Potemski P, Sclafani F, Borowiec M. Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer. Arch Immunol Ther Exp (Warsz) 2021;69:2. [PMID: 33630157 DOI: 10.1007/s00005-021-00605-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Fujisawa T, Shimamura T, Goto K, Nakagawa R, Muroyama R, Ino Y, Horiuchi H, Endo I, Maeda S, Harihara Y, Nakajima A, Matsuhashi N, Kato N, Isayama H, Puri A, Suzuki A, Bellayr I, Leland P, Joshi BH, Puri RK. A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 2020;12:E1294. [PMID: 32443847 DOI: 10.3390/cancers12051294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
35 Tong GJ, Zhang GY, Liu J, Zheng ZZ, Chen Y, Niu PP, Xu XT. Comparison of the eighth version of the American Joint Committee on Cancer manual to the seventh version for colorectal cancer: A retrospective review of our data. World J Clin Oncol 2018; 9(7): 148-161 [PMID: 30425940 DOI: 10.5306/wjco.v9.i7.148] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
36 Bonet M, Rodrigo A, Vázquez S, Carrizo V, Vilardell F, Mira M. Adjuvant therapy for true ampullary cancer: a systematic review. Clin Transl Oncol 2020;22:1407-13. [PMID: 31927720 DOI: 10.1007/s12094-019-02278-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kondo N, Murakami Y, Uemura K, Hashimoto Y, Nakagawa N, Sasaki H, Sueda T. An Increased Number of Perineural Invasions Is Independently Associated With Poor Survival of Patients With Resectable Pancreatic Ductal Adenocarcinoma. Pancreas. 2015;44:1345-1351. [PMID: 26465957 DOI: 10.1097/mpa.0000000000000413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Soer EC, Verbeke CS. Pathology reporting of margin status in locally advanced pancreatic cancer: challenges and uncertainties. J Gastrointest Oncol 2021;12:2512-20. [PMID: 34790412 DOI: 10.21037/jgo-20-391] [Reference Citation Analysis]
39 Usón Junior PL, França MS, Rodrigues HV, Macedo AL, Goldenberg A, Smaletz O, Armentano DP, Simon SD, Gansl RC. Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered. Einstein (Sao Paulo) 2015;13:347-51. [PMID: 26313433 DOI: 10.1590/S1679-45082015AO3303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
40 Stevens CL, Watters DAK. Short-term outcomes of pancreaticoduodenectomy in the state of Victoria: hospital resources are more important than volume. ANZ J Surg. 2019;89:1577-1581. [PMID: 31222880 DOI: 10.1111/ans.15298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Lad NL, Squires MH, Maithel SK, Fisher SB, Mehta VV, Cardona K, Russell MC, Staley CA, Adsay NV, Kooby DA. Is it time to stop checking frozen section neck margins during pancreaticoduodenectomy? Ann Surg Oncol. 2013;20:3626-3633. [PMID: 23838908 DOI: 10.1245/s10434-013-3080-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
42 Adamczyk LA, Gordon K, Kholová I, Meijer-Jorna LB, Telinius N, Gallagher PJ, van der Wal AC, Baandrup U. Lymph vessels: the forgotten second circulation in health and disease. Virchows Arch 2016;469:3-17. [PMID: 27173782 DOI: 10.1007/s00428-016-1945-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
43 Zakaria H, Sallam AN, Ayoub II, Gad EH, Taha M, Roshdy MR, Sweed D, Gaballa NK, Yassein T. Prognostic factors for long-term survival after pancreaticoduodenectomy for periampullary adenocarcinoma. A retrospective cohort study. Ann Med Surg (Lond) 2020;57:321-7. [PMID: 32874564 DOI: 10.1016/j.amsu.2020.07.059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Mishra SK, Kumari N, Krishnani N, Singh RK, Mohindra S. Identification and prevalence of potentially therapeutic targetable variants of major cancer driver genes in ampullary cancer patients in India through deep sequencing. Cancer Genet 2021;258-259:41-8. [PMID: 34455261 DOI: 10.1016/j.cancergen.2021.08.001] [Reference Citation Analysis]
45 Ansari D, Tingstedt B, Andersson B, Holmquist F, Sturesson C, Williamsson C, Sasor A, Borg D, Bauden M, Andersson R. Pancreatic cancer: yesterday, today and tomorrow. Future Oncol. 2016;12:1929-1946. [PMID: 27246628 DOI: 10.2217/fon-2016-0010] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 17.7] [Reference Citation Analysis]
46 Zakaria H, Sallam AN, Ayoub II, Gad EH, Taha M, Roshdy MR, Sweed D, Gaballa NK, Yassein T. Prognostic factors for long-term survival after pancreaticoduodenectomy for periampullary adenocarcinoma. A retrospective cohort study. Ann Med Surg (Lond) 2020;57:321-7. [PMID: 32874564 DOI: 10.1016/j.amsu.2020.07.059] [Reference Citation Analysis]
47 Chang ST, Jeffrey RB, Patel BN, Dimaio MA, Rosenberg J, Willmann JK, Olcott EW. Preoperative Multidetector CT Diagnosis of Extrapancreatic Perineural or Duodenal Invasion Is Associated with Reduced Postoperative Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Preliminary Experience and Implications for Patient Care. Radiology 2016;281:816-25. [DOI: 10.1148/radiol.2016152790] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
48 Barreto SG, Pandanaboyana S, Ironside N, Windsor JA. Does revision of resection margins based on frozen section improve overall survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma? A meta-analysis. HPB 2017;19:573-9. [DOI: 10.1016/j.hpb.2017.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
49 Guerard A, Ayav A, Busby H, Lafitte M, Rousseau H, Laurent V. Early liver metastases in resectable periampullary cancer: Incidence and risk factors. European Journal of Radiology 2017;93:265-72. [DOI: 10.1016/j.ejrad.2017.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
50 Chandrasegaram MD, Chiam SC, Chen JW, Khalid A, Mittinty ML, Neo EL, Tan CP, Dolan PM, Brooke-Smith ME, Kanhere H. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy. World J Surg Oncol. 2015;13:85. [PMID: 25890023 DOI: 10.1186/s12957-015-0498-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
51 Hutchings D, Waters KM, Weiss MJ, Wolfgang CL, Makary MA, He J, Cameron JL, Wood LD, Hruban RH. Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression. Am J Surg Pathol 2018;42:1556-61. [PMID: 30212393 DOI: 10.1097/PAS.0000000000001148] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
52 Lu F, Soares KC, He J, Javed AA, Cameron JL, Rezaee N, Pawlik TM, Wolfgang CL, Weiss MJ. Neoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with improved survival. Hepatobiliary Surg Nutr 2017;6:144-53. [PMID: 28652997 DOI: 10.21037/hbsn.2016.08.06] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
53 Nagakawa Y, Nakagawa N, Takishita C, Uyama I, Kozono S, Osakabe H, Suzuki K, Nakagawa N, Hosokawa Y, Shirota T, Honda M, Yamada T, Katsumata K, Tsuchida A. Reconsideration of the Appropriate Dissection Range Based on Japanese Anatomical Classification for Resectable Pancreatic Head Cancer in the Era of Multimodal Treatment. Cancers (Basel) 2021;13:3605. [PMID: 34298818 DOI: 10.3390/cancers13143605] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 John BJ, Naik P, Ironside A, Davidson BR, Fusai G, Gillmore R, Watkins J, Rahman SH. Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival. HPB (Oxford) 2013;15:674-80. [PMID: 23458477 DOI: 10.1111/hpb.12019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
55 Wang H, Jia R, Zhao T, Li X, Lang M, Lan C, Wang H, Li Z, Zhou B, Wu L, Sun Y, Wang X, Ren H, Hao J. HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma. Cancer Lett 2019;453:10-20. [PMID: 30922919 DOI: 10.1016/j.canlet.2019.03.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
56 Ye HL, Li DD, Lin Q, Zhou Y, Zhou QB, Zeng B, Fu ZQ, Gao WC, Liu YM, Chen RW, Li ZH, Chen RF. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival. World J Gastroenterol 2015; 21(21): 6621-6630 [PMID: 26074700 DOI: 10.3748/wjg.v21.i21.6621] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
57 Aitken RJ. Pancreaticoduodenectomy in Australia: a national quality improvement clinical registry is long overdue. ANZ J Surg 2022;92:6-8. [PMID: 35212115 DOI: 10.1111/ans.17395] [Reference Citation Analysis]
58 Petermann D, Demartines N, Schäfer M. Is tumour size an underestimated feature in the current TNM system for malignancies of the pancreatic head? HPB (Oxford). 2013;15:872-881. [PMID: 23458601 DOI: 10.1111/hpb.12052] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
59 Li J, Kang R, Tang D. Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma. Cancer Commun (Lond) 2021;41:642-60. [PMID: 34264020 DOI: 10.1002/cac2.12188] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Pomianowska E, Grzyb K, Westgaard A, Clausen OP, Gladhaug IP. Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancer. Eur J Surg Oncol. 2012;38:1043-1050. [PMID: 22883964 DOI: 10.1016/j.ejso.2012.07.113] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
61 Tampi CS, Nilkanth S, Jagannath P. Reporting the margin in pancreaticoduodenectomies: R0 versus R1. Indian J Gastroenterol 2017;36:81-7. [PMID: 28417289 DOI: 10.1007/s12664-017-0742-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
62 Werner J, Combs SE, Springfeld C, Hartwig W, Hackert T, Büchler MW. Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol. 2013;10:323-333. [PMID: 23629472 DOI: 10.1038/nrclinonc.2013.66] [Cited by in Crossref: 133] [Cited by in F6Publishing: 124] [Article Influence: 14.8] [Reference Citation Analysis]
63 Carr RA, Roch AM, Zhong X, Ceppa EP, Zyromski NJ, Nakeeb A, Schmidt CM, House MG. Prospective Evaluation of Associations between Cancer-Related Pain and Perineural Invasion in Patients with Resectable Pancreatic Adenocarcinoma. J Gastrointest Surg. 2017;21:1658-1665. [PMID: 28785934 DOI: 10.1007/s11605-017-3513-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
64 Rehders A, Stoecklein NH, Güray A, Riediger R, Alexander A, Knoefel WT. Vascular invasion in pancreatic cancer: tumor biology or tumor topography? Surgery. 2012;152:S143-S151. [PMID: 22766363 DOI: 10.1016/j.surg.2012.05.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
65 Soer E, Brosens L, van de Vijver M, Dijk F, van Velthuysen ML, Farina-Sarasqueta A, Morreau H, Offerhaus J, Koens L, Verheij J. Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens : An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomy specimens. Virchows Arch. 2018;472:533-543. [PMID: 29589102 DOI: 10.1007/s00428-018-2321-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
66 Werthmann PG, Kempenich R, Lang-Avérous G, Kienle GS. Long-term survival of a patient with advanced pancreatic cancer under adjunct treatment with Viscum album extracts: A case report. World J Gastroenterol 2019; 25(12): 1524-1530 [PMID: 30948915 DOI: 10.3748/wjg.v25.i12.1524] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Okada K, Uemura K, Kondo N, Sumiyoshi T, Nakagawa N, Seo S, Otsuka H, Urabe K, Murakami Y, Takahashi S. Prognostic significance of dissecting the nerve plexus around the common hepatic artery in pancreatic cancer. Langenbecks Arch Surg 2021;406:679-89. [DOI: 10.1007/s00423-020-02025-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Echrish HH, Xiao Y, Madden LA, Allgar V, Cooke J, Wedgwood K, Dasgupta D, Greenman J, Maraveyas A. Effect of resection of localized pancreaticobiliary adenocarcinoma on angiogenic markers and tissue factor related pro-thrombotic and pro-angiogenic activity. Thromb Res 2014;134:479-87. [PMID: 24929839 DOI: 10.1016/j.thromres.2014.05.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
69 Kim HR, Seo M, Nah YW, Park HW, Park SH. Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival. Nucl Med Commun 2018;39:691-8. [PMID: 29893751 DOI: 10.1097/MNM.0000000000000855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]